Indonesia

| High TB burden | High HIV burden | High MDR-TB burden | Tuberculosis profile
Population 2012 247 million
Estimates of TB burden * 2012 Number (thousands)
Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 67 (30120) 27 (1248)
Mortality (HIV+TB only) 2.1 (1.83) 0.86 (0.741.2)
Prevalence (includes HIV+TB) 730 (3501 200) 297 (144506)
Incidence (includes HIV+TB) 460 (380540) 185 (153220)
Incidence (HIV+TB only) 7.5 (5.69.7) 3.1 (2.33.9)
Case detection, all forms (%) 72 (6187)
TB case notifications 2012
New cases (%) Retreatment cases (%)
Smear-positive 202 319 (63) Relapse 5 942 (70)
Smear-negative 104 866 (32) Treatment after failure 467 (5)
Smear-unknown / not done Treatment after default 954 (11)
Extrapulmonary 15 697 (5) Other 1 179 (14)
Other
Total new 322 882 Total retreatment 8 542
Other (history unknown)
Total new and relapse 328 824 Total cases notified 331 424
New cases Smear-positive
Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.5 1.3 0.9
Age < 15 1 703 22 956 2 684
Laboratories 2012
Smear (per 100 000 population) 2.3
Culture (per 5 million population) 0.9
Drug susceptibility testing (per 5 million population) 0.1
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)
New smear-positive and/or culture-positive 90
Is rifampicin used
throughout treatment for
new patients? Yes
New smear-negative/extrapulmonary 85
Retreatment 71
TB/HIV 2012 Number (%)
TB patients with known HIV status 2 676 (<1)
HIV-positive TB patients 754 (28)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 133 (18)
HIV-positive TB patients on antiretroviral therapy (ART) 221 (29)
HIV-positive people screened for TB 22 677
HIV-positive people provided with IPT
Estimates of MDR-TB burden 2012* New Retreatment
% of TB cases with MDR-TB 1.9 (1.42.5) 12 (8.117)
MDR-TB cases among notified pulmonary
TB cases
5 800 (4 3007 700) 1 000 (6901 500)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 2 (<1%) 821 (10%) 824
Laboratory-confirmed MDR-TB cases 2 425 428
Patients started on MDR-TB treatment 426
Financing TB control 2013
National TB programme budget (US$ millions) 119
% Funded domestically 14%
% Funded internationally 35%
% Unfunded 51%
***
(Rate per 100 000 population per year)
1990 1994 1998 2002 2006 2010
0
50
100
___ Mortality (excludes HIV+TB)
(Rate per 100 000 population)
1990 1994 1998 2002 2006 2010
0
400
800
___ Prevalence
(Rate per 100 000 population per year)
1990 1994 1998 2002 2006 2010
0
100
200
300
__ Notifications ___ Incidence
___ Incidence (HIV+TB only)
Treatment success rate (%)
1995 1997 1999 2001 2003 2005 2007 2009
30
50
70
90
__ New smear-positive and/or culture-positive
__New smear-negative/extrapulmonary __
Retreatment
(Number of patients)
2003 2005 2007 2009 2011
0
1000
2000
3000
__ HIV-positive TB patients
__on CPT __on ART
Total budget (US$ millions)
2009 2010 2011 2012 2013
0
40
80
120
__ Funded domestically __ Funded internationally
__ Unfunded
Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
* Ranges represent uncertainty intervals Generated: 2014-03-21 Data: www.who.int/tb/data